A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation

<p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipi...

Full description

Bibliographic Details
Main Authors: E. I. Emelina, G. E. Gendlin
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/329
id doaj-df37b2baf8c94223b83e8d69b87ee531
record_format Article
spelling doaj-df37b2baf8c94223b83e8d69b87ee5312020-11-24T23:33:03ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-11-0111553554210.1234/1819-6446-2015-5-535-542329A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generationE. I. Emelina0G. E. Gendlin1Российский национальный исследовательский медицинский университет им. Н.И. Пирогова 117997, Москва, ул. Островитянова, 1Российский национальный исследовательский медицинский университет им. Н.И. Пирогова 117997, Москва, ул. Островитянова, 1<p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipine in certain categories of patients, including patients receiving combination therapy is also considered. The safety of lercanidipine in cardiac patients is discussed separately.<br /> </span></p>http://www.rpcardio.ru/jour/article/view/329лерканидипинартериальная гипертензиябезопасность лечения
collection DOAJ
language English
format Article
sources DOAJ
author E. I. Emelina
G. E. Gendlin
spellingShingle E. I. Emelina
G. E. Gendlin
A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
Racionalʹnaâ Farmakoterapiâ v Kardiologii
лерканидипин
артериальная гипертензия
безопасность лечения
author_facet E. I. Emelina
G. E. Gendlin
author_sort E. I. Emelina
title A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
title_short A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
title_full A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
title_fullStr A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
title_full_unstemmed A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
title_sort modern choice for patients with hypertension: the possibility of new calcium antagonist of iii generation
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-11-01
description <p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipine in certain categories of patients, including patients receiving combination therapy is also considered. The safety of lercanidipine in cardiac patients is discussed separately.<br /> </span></p>
topic лерканидипин
артериальная гипертензия
безопасность лечения
url http://www.rpcardio.ru/jour/article/view/329
work_keys_str_mv AT eiemelina amodernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration
AT gegendlin amodernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration
AT eiemelina modernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration
AT gegendlin modernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration
_version_ 1725532252406808576